Seasonality Snapshot

Gilead Sciences (GILD)

Antiviral Biotech · US · US Healthcare & Biotech
✓ VERIFIED · 15YR REAL DATA
JanFebMarAprMayJunJulAugSepOctNovDec
NEUTRAL SEASONALITY — August
Strongest Month
January
+5.19% avg · 69% win rate
Weakest Month
December
-1.47% avg · 33% win rate
MonthAvg ReturnWin Rate
January +5.19% 69%
February -0.28% 44%
March +1.62% 56%
April -0.32% 44%
May +0.81% 50%
June +1.95% 63%
July +3.06% 63%
August NOW +1.63% 56%
September +0.51% 40%
October +2.82% 67%
November +2.68% 67%
December -1.47% 33%
These figures are computed from 15 years of actual monthly closing prices. Past seasonal patterns are not a guarantee of future performance. See our methodology for how this is calculated, or visit the Academy to learn how to read seasonal data responsibly.

Gilead Sciences seasonality — common questions

What is Gilead Sciences's best month historically?
Historically, January has been Gilead Sciences's strongest month, averaging +5.19% with a 69% win rate over 15 years of data. December has been the weakest at -1.47%.
Is Gilead Sciences seasonal?
Gilead Sciences shows a measurable seasonal pattern: its best and worst months differ by 6.66 percentage points on average. These figures come from 15 years of real monthly closing prices. Seasonality is a historical tendency, not a prediction.
How does Gilead Sciences historically perform in August?
Gilead Sciences is currently in August, which has historically averaged +1.63% with a 56% win rate. That is a historically neutral window.

Get the full analysis

Backtest this seasonal pattern, compare it against other assets, set alerts, and explore detrended & presidential-cycle views.

Open the Analyzer →
TimingAX is an independently operated service, not a registered investment adviser. This page is for informational purposes only and is not financial advice.